Post Reply
1-2 of 2
Pharmesis returns to the black with a net profit attributable to equity holders of RMB8.3 million in FY2024
https://links.sgx.com/1.0.0/corporate-announcements/SRYKFFAM5P0LNGAQ/c5d85f825a6d471da329c9dfd3129b246306cda0bf0845f4608ca7e057326bc2
Holding this since IPO, then it splited 10:1, my 15k shares become 1.5k. Now regrets never buy when it was sub 10ct, if not would have already get rid of them now...